Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure
Open Access
- 1 June 2002
- journal article
- Published by Oxford University Press (OUP)
- Vol. 23 (11) , 886-891
- https://doi.org/10.1053/euhj.2001.3115
Abstract
Aims To compare the precursor of atrial and brain natriuretic peptide (N-ANP, N-BNP), brain natriuretic peptide (BNP), big endothelin-1, the 6-min walk test and the Minnesota Living with Heart Failure Questionnaire (LHFQ) with regard to short-term outcome in an ambulatory heart failure population. Methods and Results Ninety-six individuals (left ventricular ejection fraction of 26±10%) were included in the study. Within 1 day blood samples of N-ANP, N-BNP, BNP and big endothelin-1 were obtained, and the 6-min walk test and LHFQ were measured. The predictive power of these variables—including renin–angiotensin system antagonist therapy—in respect of 1-year event-free survival were calculated with a Cox regression analysis. All investigated variables had the power to predict outcome in a univariate analysis. Multivariate analysis revealed that N-ANP (chi-square=58 PPPP Conclusion We conclude that, in an open clinical cohort of patients with large differences in the progression of the disease, N-ANP, BNP and LHFQ are the most reliable predictors of worsening heart failure in the short term. However, the dosage of the ACE inhibitor influenced short-term survival in this population. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.Keywords
This publication has 0 references indexed in Scilit: